Companies → H. Lundbeck A/S
Save to list
Remove

H. Lundbeck A/S

Denmark, Hovedstaden, Valby
Updated Jul 10, 2024 10:58
Description
H. Lundbeck develops medicine primarily for the treatment of diseases of the central nervous system. Sold throughout the world, Lundbeck's main products include Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer's disease, and Azilect for the treatment of Parkinson's disease. Lundbeck spends about 20% of its revenue on research and development. The company has licensing and collaborative agreements with other drugmakers.
Address:

Ottiliavej 9 2500

Valby

Hovedstaden Denmark

Website:
Revenue
$2900M
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.